An investigation into whether tight glucose control improves mortality in patients admitted to combined Intensive Therapy Unit/High Dependency Unit (ITU/HDU)
| ISRCTN | ISRCTN31624090 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN31624090 |
| Secondary identifying numbers | N0247130746 |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 05/12/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Malcolm Watters
Scientific
Scientific
The Great Western Hospital
Marlborough Road
Swindon
SN3 6BB
United Kingdom
| abc@email.com |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Scientific title | An investigation into whether tight glucose control improves mortality in patients admitted to combined Intensive Therapy Unit/High Dependency Unit (ITU/HDU) |
| Study objectives | Does intensive glucose control improve outcome in a population of Intensive Therapy Unit/High Dependency Unit (ITU/HDU) patients? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Not Applicable |
| Intervention | Group 1: Intensive insulin therapy - the blood glucose will be maintained between 4.4 and 6.1 mmol/L using intravenous insulin therapy Group 2: Conventional insulin therapy - the blood glucose will be maintained between 10.0 and 11.1 mmol/L using intravenous insulin therapy |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Insulin |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 10/03/2003 |
| Completion date | 30/06/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | ITU/HDU patients |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 10/03/2003 |
| Date of final enrolment | 30/06/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
The Great Western Hospital
Swindon
SN3 6BB
United Kingdom
SN3 6BB
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.dh.gov.uk/Home/fs/en |
|---|
Funders
Funder type
Government
Swindon and Marlborough NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
